# Sonoelastography: Ultrasound Method to Measure Liver Fibrosis

> **NCT01747772** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 180 (actual)

## Conditions studied

- Chronic Liver Disease
- Non-Alcoholic Fatty Liver Disease
- Hepatitis C Virus (HCV) Coinfection
- Hepatitis B Virus (HBV)
- Drug-Induced Liver Injury

## Interventions

- **DEVICE:** Shear Wave Sonoelastography

## Key facts

- **NCT ID:** NCT01747772
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2014-02-14
- **Final completion:** 2014-02-14
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01747772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01747772, "Sonoelastography: Ultrasound Method to Measure Liver Fibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01747772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*